1 - Research experience and ability
|
Quality
Management |
Training and
Education |
Public
Involvement |
| Description | |
|---|---|
Name |
ITCC - Innovative Therapies for Children and Adolescents with Cancer |
| Number of completed trials | 66 |
| Number of ongoing trials | 24 |
| Total number of participants actually recruited each year | 410 |
| Proportion of eligible participants actually recruited each year | The target population are all children and adolescents with relapsed or refractory disease |
| Describe way of screening and participant recruitment | Paediatric and adolescent patients with recurrent or refractory malignancies are proposed to be included in an early clinical trial in the absence of efficient treatment strategies. Recruitment is limited due to the insufficient number of accessible trials. |
| Total number of collaborating centres | 62 |
| Academic investigator initiated studies | |
| Number of ongoing and completed clinical trials. Absolute number | 26 |
| Number of ongoing and completed clinical trials. Proportion of all studies | |
| Number of paediatric specialties covered by paediatric trials] | 3 |
| Number of paediatric conditions covered by paediatric trials] | 30 |
| Number of other ongoing research studies programs] | 4 |
| Proportion of academic initiated studies | 100% |
| Proportion of budget | 85% |
| Number of registered study participants. All studies |
1884 |
| Number of ongoing and completed trials | 42 |
| Number of paediatric specialties covered by paediatric trials | 3 |
| Number of paediatric conditions covered by paediatric trialss | 30 |
| Number of registered study participants all studies | 1817 |